| Age at onset and Parkinson disease phenotype G Pagano, N Ferrara, DJ Brooks, N Pavese Neurology 86 (15), 1400-1407, 2016 | 367 | 2016 |
| Calcium release channel RyR2 regulates insulin release and glucose homeostasis G Santulli, G Pagano, C Sardu, W Xie, S Reiken, SL D’ascia, M Cannone, ... The Journal of clinical investigation 125 (5), 1968-1978, 2015 | 254 | 2015 |
| Diabetes mellitus and Parkinson disease G Pagano, S Polychronis, H Wilson, B Giordano, N Ferrara, F Niccolini, ... Neurology 90 (19), e1654-e1662, 2018 | 212 | 2018 |
| Imaging in Parkinson’s disease G Pagano, F Niccolini, M Politis Clinical Medicine 16 (4), 371, 2016 | 212 | 2016 |
| Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease Z Qamhawi, D Towey, B Shah, G Pagano, J Seibyl, K Marek, ... Brain 138 (10), 2964-2973, 2015 | 211 | 2015 |
| Trial of prasinezumab in early-stage Parkinson’s disease G Pagano, KI Taylor, J Anzures-Cabrera, M Marchesi, T Simuni, K Marek, ... New England Journal of Medicine 387 (5), 421-432, 2022 | 181 | 2022 |
| Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease J Schulz, G Pagano, JA Fernández Bonfante, H Wilson, M Politis Brain 141 (5), 1501-1516, 2018 | 177 | 2018 |
| β-adrenergic receptor responsiveness in aging heart and clinical implications N Ferrara, K Komici, G Corbi, G Pagano, G Furgi, C Rengo, ... Frontiers in physiology 4, 396, 2014 | 171 | 2014 |
| Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis G Savarese, F Musella, C D’Amore, E Vassallo, T Losco, F Gambardella, ... JACC: heart failure 2 (2), 148-158, 2014 | 168 | 2014 |
| Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis G Pasqualetti, G Pagano, G Rengo, N Ferrara, F Monzani The Journal of Clinical Endocrinology & Metabolism 100 (11), 4240-4248, 2015 | 167 | 2015 |
| Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment A Chandra, PE Valkimadi, G Pagano, O Cousins, G Dervenoulas, ... Human brain mapping 40 (18), 5424-5442, 2019 | 156 | 2019 |
| Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis G Pagano, G Rengo, G Pasqualetti, GD Femminella, F Monzani, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (7), 767-773, 2015 | 142 | 2015 |
| Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature GD Femminella, G Rengo, K Komici, P Iacotucci, L Petraglia, G Pagano, ... Journal of Alzheimer's Disease 42 (2), 369-377, 2014 | 139 | 2014 |
| REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease G Pagano, R De Micco, T Yousaf, H Wilson, A Chandra, M Politis Neurology 91 (10), e894-e905, 2018 | 125 | 2018 |
| Cholinergic imaging in dementia spectrum disorders R Roy, F Niccolini, G Pagano, M Politis European journal of nuclear medicine and molecular imaging 43, 1376-1386, 2016 | 104 | 2016 |
| Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure V Parisi, G Rengo, P Perrone-Filardi, G Pagano, GD Femminella, ... Circulation research 118 (8), 1244-1253, 2016 | 94 | 2016 |
| Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studies G Pagano, F Niccolini, P Fusar‐Poli, M Politis Annals of neurology 81 (2), 171-180, 2017 | 93 | 2017 |
| Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure: A 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study S Paolillo, G Rengo, G Pagano, T Pellegrino, G Savarese, ... Diabetes care 36 (8), 2395-2401, 2013 | 91 | 2013 |
| Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α2-adrenoceptor-catecholamine production axis in heart failure G Rengo, A Lymperopoulos, C Zincarelli, GD Femminella, D Liccardo, ... British journal of pharmacology 166 (8), 2430-2439, 2012 | 88 | 2012 |
| β1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and … A Cannavo, G Rengo, D Liccardo, G Pagano, C Zincarelli, MC De Angelis, ... Circulation 128 (15), 1612-1622, 2013 | 84 | 2013 |
Marios PolitisProfessor of Neurology @ University of Exeter在 exeter.ac.uk 的电子邮件经过验证
